Trial
NCT05058859
Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
—
Condition
Cystinuria
Intervention
Dapagliflozin
Why stopped
Funding was never secured so clinical trial was never started; this study was abandoned
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-29